Cagrilintide side effects include nausea, vomiting, fatigue, and injection site reactions. Learn what trials show about cagrilintide safety and FDA status.
Cagrilintide side effects are primarily gastrointestinal and include nausea, vomiting, diarrhea, constipation, and fatigue. Cagrilintide is an investigational amylin analog that is not FDA-approved for any human use, and it is not a GLP-1 receptor agonist. In clinical trials, most side effects were mild to moderate and happened during dose increases.
What Is Cagrilintide and Is It FDA-Approved?
Cagrilintide is a long-acting amylin analog. It is designed to mimic amylin, a hormone that helps regulate blood sugar and feelings of fullness. Researchers are studying it for chronic weight management and type 2 diabetes, often in combination with semaglutide under the name CagriSema.
Is cagrilintide a GLP-1? No. Cagrilintide is not a GLP-1 receptor agonist. It works on amylin receptors, which is a different pathway than GLP-1 drugs like semaglutide or tirzepatide.
Is cagrilintide FDA-approved? No. As of this writing, cagrilintide has not received FDA approval for any indication. It remains an investigational drug, so it should only be used within a clinical trial or under close medical supervision.
Because cagrilintide is not approved, products sold online as "research grade" cagrilintide are unregulated. Their purity, dose, and safety are unknown. The FDA has warned consumers about buying peptides from unverified sources.
Common Cagrilintide Side Effects
The most frequently reported side effects of cagrilintide in clinical trials include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Fatigue
- Injection site reactions
- Headache
- Abdominal pain
- Decreased appetite
Most of these effects are temporary and ease as the body adjusts. However, some people experience symptoms severe enough to stop treatment.
Cagrilintide Nausea and Gastrointestinal Effects
Nausea is the most common cagrilintide side effect. In trials, nausea was reported by a significant portion of participants, especially at higher doses. Vomiting and diarrhea can also occur, though less often.
Constipation is another frequent complaint. It may be related to slower digestion or reduced food intake. Staying hydrated and eating small, bland meals may help, but you should talk to a clinician before trying any self-treatment.
Severe or persistent gastrointestinal symptoms can lead to dehydration or electrolyte imbalance. Seek medical care if you cannot keep fluids down or have severe abdominal pain.
Cagrilintide Fatigue and Other Systemic Side Effects
Fatigue is a commonly reported cagrilintide side effect. People searching for "cagrilintide side effects fatigue" often want to know whether tiredness is normal. In trials, fatigue was reported alongside nausea and reduced appetite, and it may be linked to lower calorie intake or the drug's effect on metabolism.
Other systemic effects may include headache, dizziness, and injection site reactions like redness or swelling. These are usually mild.
If fatigue interferes with daily life, a healthcare professional can check for other causes, such as anemia, thyroid issues, or dehydration.
Is Cagrilintide Safe? What the Research Shows
In clinical trials, cagrilintide was generally tolerated, but it is not risk-free. Discontinuation rates due to side effects were low but not zero. The long-term safety of cagrilintide is still unknown because studies are ongoing.
Serious risks may include:
- Hypoglycemia when combined with insulin or sulfonylureas
- Gallbladder disease, such as gallstones
- Pancreatitis (rare, but reported with similar drugs)
- Severe allergic reactions
Cagrilintide safety has not been established for pregnant or breastfeeding women, children, or people with a history of pancreatitis or severe kidney problems. Always discuss your full medical history with a doctor.
Cagrilintide Overdose: What Happens?
There is no specific antidote for a cagrilintide overdose. Taking too much may worsen nausea, vomiting, and diarrhea, leading to dehydration. It could also increase the risk of hypoglycemia if you take insulin or other diabetes medications.
If you suspect an overdose, contact Poison Control or seek emergency medical help immediately. Do not wait for symptoms to become severe.
Cagrilintide Side Effects Reddit and Online Reports
Online forums like Reddit contain many anecdotal reports about cagrilintide. Users often mention nausea, fatigue, and injection site reactions. Some people also discuss reta cagri blend side effects when combining cagrilintide with other peptides. These stories can be helpful for emotional support, but they are not scientific evidence.
Remember that people are more likely to post about bad experiences than good ones. Clinical trial data remains the most reliable source for side effect rates.
Cagrilintide vs. GLP-1 Side Effects
Cagrilintide is often compared to GLP-1 drugs because both are used for weight loss. However, they work on different receptors and have somewhat different side effect profiles.
| Side Effect | Cagrilintide (amylin analog) | GLP-1 drugs (e.g., semaglutide) |
|---|---|---|
| Nausea | Common | Common |
| Vomiting | Common | Common |
| Diarrhea | Common | Common |
| Constipation | Common | Common |
| Fatigue | Reported | Less commonly reported |
| Injection site reactions | Common | Common |
| Hypoglycemia | Risk when combined with insulin | Risk when combined with insulin |
Combining cagrilintide with a GLP-1 may increase gastrointestinal side effects. That is one reason combination therapy is only used in supervised trials.
If you are exploring other options, you may also read about lipo c injection side effects or aod-9604 benefits and side effects. Each product has its own risk profile, and none are FDA-approved for weight loss except certain prescription medications.
When to Call a Healthcare Professional
Contact a doctor if you experience:
- Persistent vomiting or diarrhea
- Signs of dehydration (dark urine, dizziness, dry mouth)
- Severe or ongoing abdominal pain
- Blood sugar drops (shakiness, confusion, sweating)
- Any severe allergic reaction (rash, swelling, trouble breathing)
You should also ask about cjc 1295 long-term side effects or other peptides if you are considering stacking them. Never mix investigational peptides without medical guidance.
Bottom Line
Cagrilintide side effects are mostly gastrointestinal and include nausea, vomiting, diarrhea, constipation, and fatigue. Cagrilintide is not FDA-approved, and it is not a GLP-1 drug. Most side effects are manageable but can be serious in some cases. If you are considering cagrilintide, do so only under the care of a qualified healthcare professional or within a clinical trial.
Frequently Asked Questions
Is cagrilintide FDA-approved?
No. Cagrilintide is not FDA-approved for any indication. It is an investigational amylin analog still being studied in clinical trials. It should only be used under medical supervision or within a trial setting.
Is cagrilintide a GLP-1?
No. Cagrilintide is an amylin analog, not a GLP-1 receptor agonist. It targets amylin receptors, which are involved in satiety and blood sugar regulation. It is often combined with the GLP-1 drug semaglutide in clinical trials.
What are the most common cagrilintide side effects?
The most common side effects are nausea, vomiting, diarrhea, constipation, and fatigue. Injection site reactions and headache are also reported. Most are mild to moderate and occur during dose increases.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.